- Rongioletti F, Ferreli C, Sena P, Caputo V, Atzori L. Clinicopathologic correlations of COVID-19-related cutaneous manifestations with special emphasis on histopathologic patterns. Clin Dermatol. 2021;39(1):149–162. doi:10.1016/j.clindermatol.2020.12.004.
- Bennardo L, Nisticò SP, Dastoli S, et al. Erythema multiforme and COVID-19: what do we know? Med Kaunas Lith. 2021;57(8):828. doi:10.3390/medicina57080828.
- Sokumbi O, Wetter DA. Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist. Int J Dermatol. 2012;51(8):889–902. doi:10.1111/j.1365-4632.2011.05348.x.
- Recalcati S, Barbagallo T, Frasin LA, et al. Acral cutaneous lesions in the time of COVID-19. J Eur Acad Dermatol Venereol. 2020;34(8):e346–e347. doi:10.1111/jdv.16533.
- Khalid M, Lipka O, Becker C. Moderna COVID-19 vaccine induced skin rash. Vis J Emerg Med. 2021;25:101–108.
- Zhang LW, Wang WJ, Li CH, Chen T. Erythema multiforme after SARS-CoV-2 vaccine. J Eur Acad Dermatol Venereol. 2022;36(1):e32–e33. doi:10.1111/jdv.17689.
- Burlando M, Herzum A, Micalizzi C, Cozzani E, Parodi A. Cutaneous reactions to COVID-19 vaccine at the dermatology primary care. Immun Inflamm Dis. 2022;10(2):265–271. doi:10.1002/iid3.568.
- Kim MJ, Kim JW, Kim MS, Choi SY, Na JI. Generalized erythema multiforme-like skin rash following the first dose of COVID-19 vaccine (Pfizer-BioNTech). Acad Dermatol Venereol. 2022;36(2):98–100. doi:10.1111/jdv.17757.
- Buján Bonino C, Moreiras Arias N, López‐Pardo Rico M, et al. Atypical erythema multiforme related to BNT162b2 (Pfizer–BioNTech) COVID-19 vaccine. Int J Dermatol. 2021;60(11):466–467. doi:10.1111/ijd.15894.
- Pourani MR, Shahidi Dadras M, Salari M, Diab R, Namazi N, Abdollahimajd F. Cutaneous adverse events related to COVID-19 vaccines: a cross-sectional questionnaire-based study of 867 patients. Dermatol Ther. 2022;35(2):e15223. doi:10.1111/dth.15223.
- McMahon DE, Kovarik CL, Damsky W, et al. Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: a registry-based study. J Am Acad Dermatol. 2022;86(1):113–121. doi:10.1016/j.jaad.2021.09.002.
Erythema multiforme after third COVID-19 vaccination (Pfizer-BioNTech)
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.